He, Michael Y. http://orcid.org/0000-0002-2235-2758
Halford, Michael M.
Liu, Ruofei
Roy, James P.
Grant, Zoe L.
Coultas, Leigh http://orcid.org/0000-0001-6466-0890
Thio, Niko
Gilan, Omer http://orcid.org/0000-0003-4156-2619
Chan, Yih-Chih http://orcid.org/0000-0003-2177-5406
Dawson, Mark A. http://orcid.org/0000-0002-5464-5029
Achen, Marc G.
Stacker, Steven A. http://orcid.org/0000-0003-4096-9273
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1176732, APP1053535, APP1154746)
Article History
Received: 14 December 2020
Accepted: 23 June 2021
First Online: 15 July 2021
Competing interests
: S.A.S. and M.G.A. are shareholders of Opthea Ltd., a company involved in developing therapeutics and diagnostics for vascular targets. The remaining authors declare no competing interests.